Anti-LAMP-2 Antibody Seropositivity in Children with Primary Systemic Vasculitis Affecting Medium- and Large-Sized Vessels
Authors:
- Tayfun Hilmi AkbabaTayfun Hilmi Akbaba
- Kirandeep K. ToorKTKirandeep K. Toor
- Simranpreet K. MannSMSimranpreet K. Mann
- Kristen M. GibsonKGKristen M. Gibson
- Gabriel Alejandro AlfaroGAGabriel Alejandro Alfaro
- Banu Balci-PeynirciogluBBBanu Balci-Peynircioglu
- David A. CabralDCDavid A. Cabral
- Kimberly A. MorishitaKMKimberly A. Morishita
- Kelly L. BrownKBKelly L. Brown
Open Access
- 28 March 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (7) , 3771
Abstract
Chronic primary systemic vasculitis (PSV) comprises a group of heterogeneous diseases that are broadly classified by affected blood vessel size, clinical traits and the presence (or absence) of anti-neutrophil cytoplasmic antibodies (ANCA) against proteinase 3 (PR3) and myeloperoxidase (MPO). In small vessel vasculitis (SVV), ANCA are not present in all patients, and they are rarely detected in patients with vasculitis involving medium (MVV) and large (LVV) blood vessels. Some studies have demonstrated that lysosome-associated membrane protein-2 (LAMP-2/CD107b) is a target of ANCA in SVV, but its presence and prognostic value in childhood MVV and LVV is not known. This study utilized retrospective sera and clinical data obtained from 90 children and adolescents with chronic PSV affecting small (SVV, n = 53), medium (MVV, n = 16), and large (LVV, n = 21) blood vessels. LAMP-2-ANCA were measured in time-of-diagnosis sera using a custom electrochemiluminescence assay. The threshold for seropositivity was established in a comparator cohort of patients with systemic autoinflammatory disease. The proportion of LAMP-2-ANCA-seropositive individuals and sera concentrations of LAMP-2-ANCA were assessed for associations with overall and organ-specific disease activity at diagnosis and one-year follow up. This study demonstrated a greater time-of-diagnosis prevalence and sera concentration of LAMP-2-ANCA in MVV (52.9% seropositive) and LVV (76.2%) compared to SVV (45.3%). Further, LAMP-2-ANCA-seropositive individuals had significantly lower overall, but not organ-specific, disease activity at diagnosis. This did not, however, result in a greater reduction in disease activity or the likelihood of achieving inactive disease one-year after diagnosis. The results of this study demonstrate particularly high prevalence and concentration of LAMP-2-ANCA in chronic PSV that affects large blood vessels and is seronegative for traditional ANCA. Our findings invite reconsideration of roles for autoantigens other than MPO and PR3 in pediatric vasculitis, particularly in medium- and large-sized blood vessels.Keywords
Funding Information
- Canadian Institutes of Health Research (TR2-119188, PJT-180302)
- Global Affairs Canada Go-Global Study in Canada Scholarship (TR2-119188, PJT-180302)
- Centre for Blood Research graduate award and a Women+ and Children’s Health Sciences Diversity Award (TR2-119188, PJT-180302)
- Canadian Institutes of Health Research Graduate Student Scholarship (CGS-M) and a BC Children’s Hospital Graduate Student Award (TR2-119188, PJT-180302)
- University of British Columbia Four-Year Fellowship (TR2-119188, PJT-180302)
- Arthritis Society Canada (TR2-119188, PJT-180302)
- BC Children’s Hospital Salary Award and a Michael Smith Foundation for Health Research Scholar Award (TR2-119188, PJT-180302)
This publication has 42 references indexed in Scilit:
- Periodic fever syndromes and the autoinflammatory diseases (AIDs)Journal of Translational Autoimmunity, 2020
- Early Outcomes in Children With Antineutrophil Cytoplasmic Antibody–Associated VasculitisArthritis & Rheumatology, 2017
- Vasculitis syndrome—diagnosis and therapyJournal of General and Family Medicine, 2017
- Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort StudyArthritis & Rheumatology, 2016
- Factors Determining the Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3Arthritis & Rheumatology, 2016
- HLA–DPB1 as a Risk Factor for Relapse in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: A Cohort StudyArthritis & Rheumatology, 2016
- Classification of antineutrophil cytoplasmic autoantibody vasculitides: The role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosisArthritis & Rheumatism, 2012
- Classification, presentation, and initial treatment of Wegener's granulomatosis in childhoodArthritis & Rheumatism, 2009
- Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagyMolecular Aspects of Medicine, 2006
- The American College of Rheumatology 1990 criteria for the classification of vasculitis: SummaryArthritis & Rheumatism, 1990